Pharmaco-Fakery

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2004, Volume 28, Issue 11

On the other hand, if we don't keep up the pressure on counterfeiting in the US, we may share the plight of the developing world, where nearly 25% of all drugs sold are fakes.

Related Content:

From the EditorProcess ValidationQuality SystemsViewpointsDevelopmentPharmaceutical Technology-12-02-2004
Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients
Navigating an Uncertain Regulatory Environment for mRNA-based Products
INTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy Facilities